In December 2021, a team of researchers at Texas Children's Hospital and Baylor College of Medicine received Emergency Use Authorization (EUA) approval from the Drugs Controller General of India (DCGI) to launch their low-cost and patent-free Corbevax COVID-19 vaccine in India. Utilizing traditional recombinant protein-based technology, "The World's Covid-19 Vaccine" has the potential to change the face of vaccine accessibility. Peter J. Hotez, MD, PhD, the principal developer of the Corbevax production team, will lead a virtual discussion on vaccine equity and humanitarian action through science in this keynote event of WVU's 2022 Global Health Week.
Peter J. Hotez, MD, PhD, the principal developer of the Corbevax production team, will lead a virtual discussion on vaccine equity and humanitarian action through science in this keynote event of WVU's 2022 Global Health Week.
- Collection:
- Global Health Week
- Category:
- Celebration & Awareness, Medical
- Audience Type:
- Faculty, Staff, Alumni, Open to All
- Related Links:
- Global Health Week 2022